Pharmacological hypothesis: A recombinant probiotic for taming bacterial β‐glucuronidase in drug‐induced enteropathy
Abstract Advances in pharmacomicrobiomics have shed light on the pathophysiology of drug‐induced enteropathy associated with the therapeutic use of certain non‐steroidal anti‐inflammatory drugs, anticancer chemotherapies and immunosuppressants. The toxicity pathway results from the post‐glucuronidat...
Saved in:
Main Authors: | Manon Jardou (Author), Clarisse Brossier (Author), Kenza Guiyedi (Author), Quentin Faucher (Author), Roland Lawson (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alteration of the gut microbiome in mycophenolate-induced enteropathy: impacts on the profile of short-chain fatty acids in a mouse model
by: Manon Jardou, et al.
Published: (2021) -
α-Glucosidase and Bacterial β-Glucuronidase Inhibitors from the Stems of <i>Schisandra sphaerandra</i> Staph
by: Guiwei Rao, et al.
Published: (2022) -
Presence of benznidazole conjugated metabolites in urine identified by β-glucuronidase treatment
by: María Elena Marson, et al.
Published: (2020) -
Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase
by: Bei Yue, et al.
Published: (2021) -
The Taming of the Shrew
by: Shakespeare, William, 1564-1616